Canopy Growth Files Definitive Proxy Statement

Ticker: CGC · Form: DEFA14A · Filed: 2024-03-01T00:00:00.000Z

Sentiment: neutral

Topics: proxy-statement, regulatory-filing, shareholder-communication

TL;DR

Canopy Growth filed its proxy statement, get ready to vote.

AI Summary

Canopy Growth Corp. is filing a Definitive Proxy Statement (DEFA14A) on March 1, 2024. This filing is related to the company's proxy materials, which are typically used to solicit votes from shareholders for annual meetings or special events. The filing does not contain specific financial details or proposals but serves as a formal notification to the SEC regarding the distribution of proxy information.

Why It Matters

This filing is a standard regulatory requirement for public companies to communicate with shareholders about important corporate matters, such as voting on board members or significant corporate actions.

Risk Assessment

Risk Level: low — This is a routine regulatory filing for a proxy statement, not indicating any immediate financial or operational risk.

Key Players & Entities

FAQ

What type of filing is this DEFA14A for Canopy Growth Corp.?

This is a Definitive Proxy Statement (DEFA14A) filed by Canopy Growth Corp.

When was this filing submitted to the SEC?

The filing was submitted on March 1, 2024.

What is the Central Index Key (CIK) for Canopy Growth Corp.?

The CIK for Canopy Growth Corp. is 0001737927.

What is the SEC file number associated with this filing?

The SEC file number is 001-38496.

What is the business address of Canopy Growth Corp. as listed in the filing?

The business address is 1 Hershey Drive, Smith Falls, A6, K7A0A8.

From the Filing

0001104659-24-030057.txt : 20240301 0001104659-24-030057.hdr.sgml : 20240301 20240301171912 ACCESSION NUMBER: 0001104659-24-030057 CONFORMED SUBMISSION TYPE: DEFA14A PUBLIC DOCUMENT COUNT: 2 FILED AS OF DATE: 20240301 DATE AS OF CHANGE: 20240301 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Canopy Growth Corp CENTRAL INDEX KEY: 0001737927 STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: Z4 FISCAL YEAR END: 0331 FILING VALUES: FORM TYPE: DEFA14A SEC ACT: 1934 Act SEC FILE NUMBER: 001-38496 FILM NUMBER: 24711631 BUSINESS ADDRESS: STREET 1: 1 HERSHEY DRIVE CITY: SMITH FALLS STATE: A6 ZIP: K7A0A8 BUSINESS PHONE: 855-558-9333 MAIL ADDRESS: STREET 1: 1 HERSHEY DRIVE CITY: SMITH FALLS STATE: A6 ZIP: K7A0A8 DEFA14A 1 tm246792d3_defa14a.htm DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant x Filed by a Party other than the Registrant ¨ Check the appropriate box: ¨          Preliminary Proxy Statement ¨          Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ¨          Definitive Proxy Statement x         Definitive Additional Materials ¨          Soliciting Material under §240.14a-12 CANOPY GROWTH CORPORATION (Name of Registrant as Specified in Its Charter) N/A (Name of Person(s) Filing Proxy Statement, if other than the Registrant) Payment of Filing Fee (Check all boxes that apply): x          No fee required ¨          Fee paid previously with preliminary materials. ¨          Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11. Dear Shareholder We are very excited to be advancing our Canopy USA, LLC (“ Canopy USA ”) strategy to accelerate entry into the U.S. cannabis industry and unleash the value of its full U.S. cannabis ecosystem. We believe this strategy will make Canopy Growth Corporation (“ Canopy Growth ” or “ Company ”) the first and only U.S. listed company offering shareholders a unique opportunity to gain exposure to the fastest growing cannabis market in the world through what will be Canopy Growth’s unconsolidated interest in Canopy USA. For the next step in executing this strategy, we have scheduled a special shareholder meeting for April 12, 2024 (the “ Meeting ”) during which shareholders of Canopy Growth (the “ Shareholders ”) will be asked to consider, and if deemed appropriate, pass a special resolution authorizing an amendment to the Company’s articles of incorporation, as amended, (the “ Amendment Proposal ”) in order to: (i) create and authorize the issuance of an unlimited number of a new class of non-voting and non-participating exchangeable shares in the capital of Canopy Growth (the “ Exchangeable Shares ”); and (ii) restate the rights of the common shares in the capital of Canopy Growth to provide for a conversion feature whereby each share may at any time, at the option of the holder, be converted into one Exchangeable Share. The Meeting will be conducted in virtual format by live audio webcast at: www.virtualshareholdermeeting.com/WEED2024SM. YOUR VOTE IS IMPORTANT NO MATTER HOW MANY SHARES YOU HOLD. Please vote your shares today Canopy Growth’s board of directors recommends that Shareholders

View on Read The Filing